NOXX Therapeutics
Boca Raton, US · Founded 2023 · Delaware corporation
Founders & leadership
BP
BRIAN P MOONEYExecutive
KG
KURT GEHLSENNamed on SEC filing
Board
DA
DAVE ADAMSBoard director
RF
ROBERT FINIZIOBoard director
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 2 rounds · 2023–2026
▶$1MraisedMar 2026 · 11 investors · PharmaceuticalsRule 506(b)
▶$1MraisedMar 2026 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT FINIZIODirector
- BRIAN P MOONEYExecutive Officer, Director
- DAVE ADAMSDirector
- KURT GEHLSENExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$500KraisedOct 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedOct 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- KURT GEHLSENExecutive Officer, Director
- BRIAN MOONEYExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has NOXX Therapeutics raised?
- NOXX Therapeutics has disclosed $1.5M raised across 2 rounds.
- Where is NOXX Therapeutics headquartered?
- NOXX Therapeutics is headquartered in Boca Raton, US.